Vascular Biogenics' IPO

Vascular Biogenics raised a round of funding on July 31, 2014. Investors include Public.

Vascular Biogenics (VBL) is an innovative and diversified, clinical stage biotechnology company committed to the discovery, development and commercialization of novel treatments for cancer and immune-…

Articles about Vascular Biogenics' IPO: